Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/2722
Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.
O'Brien Thomas R.
Thomas David L.
Jackson Sarah S.
Prokunina-Olsson Ludmila.
Donnelly Raymond P.
Hartmann Rune.
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1093/cid/ciaa453
Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2020
Artículo
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184357/pdf/main.pdf
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
1102459.pdf274.14 kBAdobe PDFView/Open